Corporate insider profile
Suma Krishnan Insider Trades
Suma Krishnan has reported no open-market purchases on SEC Form 4 and is a net seller of $16,685,810 across 1 company. The most recent open-market transaction was reported on Sep 4, 2026. Source: SEC Form 4 filings.
Latest reported as President, R&D of Krystal Biotech, Inc. (KRYS).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$16,685,810.00
- Latest transaction
- Sep 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Suma Krishnan insider trading FAQ
- Is Suma Krishnan buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Suma Krishnan is a net seller of $16,685,810, with no open-market purchases reported. The latest transaction was reported on Sep 4, 2026.
- Which companies does Suma Krishnan report insider trades for?
- Suma Krishnan has reported open-market trades in Krystal Biotech, Inc. (KRYS). The latest SEC-reported relationship is President, R&D of Krystal Biotech, Inc. (KRYS).
- Where does Suma Krishnan's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1298711, and refreshes this page daily.
